Product NDC: | 63323-365 |
Proprietary Name: | Octreotide |
Non Proprietary Name: | OCTREOTIDE ACETATE |
Active Ingredient(s): | 50 ug/mL & nbsp; OCTREOTIDE ACETATE |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-365 |
Labeler Name: | Fresenius Kabi USA, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077457 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060314 |
Package NDC: | 63323-365-01 |
Package Description: | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-365-01) > 1 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 63323-365-01 |
Proprietary Name | Octreotide |
Package Description | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-365-01) > 1 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 63323-365 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | OCTREOTIDE ACETATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20060314 |
Marketing Category Name | ANDA |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | OCTREOTIDE ACETATE |
Strength Number | 50 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |